483
Nexus Pharmaceuticals, LLCFDA 483 - Nexus Pharmaceuticals, LLC - November 22, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Nexus Pharmaceuticals Inc, a control testing laboratory in Lincolnshire, IL, identified deficiencies within its quality control unit. The firm failed to ensure that responsibilities and procedures were in writing and fully followed, particularly concerning the timely and thorough investigation of product quality complaints. Additionally, the complaint handling procedure did not identify the correct responsible party.
Open in Dashboard
ID · fa5e6e29-7911-49ca-8869-54063d19d85d